GPT and liver failure: The DEB‐TACE group showed lower incidence rates of hepatic failure (5.7% vs. 20.8%, p = 0.045) and elevated ALT and TBil levels (7.5% vs. 28.3%, p = 0.011; 11.3% vs. 34.0%, p = 0.005, respectively) within 30 days than the cTACE group (Table 4).